As of 2025-11-07, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.1x | 12.0x |
| Forward P/E multiples | 12.7x - 15.2x | 13.6x |
| Fair Price | (109.29) - (112.65) | (110.17) |
| Upside | -209.3% - -212.7% | -210.2% |
| Date | EV/EBITDA |